| Literature DB >> 19217286 |
Tjeerd Barf1, Fredrik Lehmann, Kristin Hammer, Saba Haile, Eva Axen, Carmen Medina, Jonas Uppenberg, Stefan Svensson, Lena Rondahl, Thomas Lundbäck.
Abstract
Small molecule inhibitors of adipocyte fatty-acid binding protein (A-FABP) have gained renewed interest following the recent publication of pharmacologically beneficial effects of such inhibitors. Despite the potential utility of selective A-FABP inhibitors within the fields of metabolic disease, inflammation and atherosclerosis, there are few examples of useful A-FABP inhibitors in the public domain. Herein, we describe the optimization of N-benzyl-tetrahydrocarbazole derivatives through the use of co-crystal structure guided medicinal chemistry efforts. This led to the identification of a potent and selective class of A-FABP inhibitors as illustrated by N-benzyl-hexahydrocyclohepta[b]indole 30.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19217286 DOI: 10.1016/j.bmcl.2009.01.084
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823